• Thurs news: Novartis not joining weight loss race. Pharma marketing and climate change. Roche flu treatment trial. Cercle’s fund raise for women’s health. ICER looks at GSK COPD drugs. See more on our front page

At Viatris' request, US agency will review another Novo Nordisk patent on semaglutide

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Oct 05, 2023 at 10:32: AM
via In Viatris' attempt to become the first company to reach the market with generic versions of Novo Nordisk’s diabetes and obesity juggernauts Ozempic and Wegovy, the company received good and bad news this week.

article source
 

<



Similar threads

cafead
Novartis, Viatris face new lawsuit over &#039;HeLa&#039; cell misuse claims
Replies
0
Views
30
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Viatris&#039; launch plans scuttled as FDA rebuffs long-acting MS drug from partner Mapi
Replies
0
Views
158
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
J&amp;J beats back Viatris&#039; generic challenge to schizophrenia med Invega Trinza
Replies
0
Views
100
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
FDA rejects Biocon and Viatris&#039; Avastin biosimilar after inspection question marks
Replies
0
Views
294
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
J&amp;J&#039;s Momenta calls infringement against Viatris&#039; Copaxone generic, but why now?
Replies
0
Views
118
Pharma/Biotech Companies - In the News
cafead
cafead
Top Bottom
Back
Quote